Buy Tesamorelin in Canada: The 2026 Sourcing Guide for Egrifta and Research-Grade Sourcing
Quick Answer Box
Where do you buy tesamorelin in Canada in 2026? Tesamorelin sits in two separate Canadian markets: (1) approved prescription medication, Egrifta SV (made by Theratechnologies, a Canadian biopharmaceutical company), picked up from licensed Canadian pharmacies with a prescription, and (2) research-grade tesamorelin sold by domestic Canadian peptide suppliers strictly for laboratory research use only.
For research-grade tesamorelin, the top domestic option is Nox Peptides. They’re currently the only Canadian retail-facing supplier publishing both purity and endotoxin lab reports per batch. Other verified Canadian suppliers carrying research-grade tesamorelin include Canadian Peptides, Polar Peptides, Peptide Warehouse, Growth Guys, NCRP, Clinical Peptides, Amino Pure Canada, Purity Peptides, VPeptide, PeptidePro Canada, and Boss Peptides.
Tesamorelin essentials:
- What it is: A synthetic analog of growth hormone-releasing hormone (GHRH), a 44-amino-acid peptide that triggers the pituitary gland to release the body’s own growth hormone.
- Approved use in Canada: Egrifta SV is approved by Health Canada for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.
- Canadian connection: Tesamorelin was developed by Theratechnologies, a Montreal-based biopharmaceutical company. Egrifta SV is one of the few peptide drugs that came out of Canadian pharmaceutical research.
- Research-grade pricing: Roughly CAD $80 to $200 per vial depending on dosage strength.
- Status of research-grade product: Sold strictly for laboratory research use only, not for human consumption.
π The Two Tesamorelin Markets β Which One Are You Looking For?
Like semaglutide and tirzepatide, tesamorelin lives in two completely separate regulatory and commercial categories in Canada:
| Market | What It Is | How to Get It | Approximate 2026 Cost |
|---|---|---|---|
| Approved Prescription Drug | Egrifta SV (made by Theratechnologies) | Prescription from a licensed Canadian healthcare provider; dispensed by a licensed Canadian pharmacy | Premium pricing, typically CAD $2,000+/month; specialized indication coverage |
| Research-Grade Compound | Synthesized tesamorelin sold for laboratory research use | Domestic Canadian research peptide supplier; no prescription required | ~CAD $80β$200 per vial |
The two markets carry different products, sit under different regulatory rules, price differently, and serve different uses. Approved prescription drugs carry an 8-digit Drug Identification Number (DIN) and have gone through the clinical safety and efficacy review required for Canadian pharmaceutical authorization. Research-grade peptides have not, and are sold strictly for in-vitro laboratory and experimental research.
One feature that sets tesamorelin apart from the GLP-1 class compounds: tesamorelin’s approved indication is highly specialized. Egrifta SV is specifically authorized for HIV-associated lipodystrophy, not general weight management or growth hormone deficiency. That narrow indication is why prescription tesamorelin sits at premium pricing with limited provincial drug plan coverage, while research-grade tesamorelin keeps seeing strong demand for broader pharmacological research.
What Tesamorelin Actually Is β The GHRH Analog Mechanism
Tesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone (GHRH), a peptide that’s naturally produced in the hypothalamus. The compound’s mechanism works very differently from GLP-1 class peptides like semaglutide and tirzepatide:
| Mechanism Step | What Happens |
|---|---|
| 1. Tesamorelin binds GHRH receptors | The compound mimics the body’s own GHRH at the pituitary gland |
| 2. Pituitary releases growth hormone (GH) | The body’s own GH production gets stimulated, not replaced |
| 3. GH travels through the body | Acts on liver, muscle, adipose tissue, and other targets |
| 4. Liver produces IGF-1 | GH triggers downstream IGF-1 production, the main mediator of GH effects |
| 5. Adipose tissue effects | Particularly visceral adipose tissue reduction, which is the basis for the HIV lipodystrophy indication |
This part matters: tesamorelin is a secretagogue. It triggers the body’s own GH release rather than replacing GH directly. That’s a meaningfully different pharmacological category from exogenous growth hormone therapy.
π Tesamorelin vs Other GH-Related Research Peptides
| Compound | Mechanism Class | Research Focus | Approved Indication |
|---|---|---|---|
| Tesamorelin | GHRH analog (44 AA) | Pulsatile GH release; visceral fat research | HIV-associated lipodystrophy (Health Canada approved) |
| Sermorelin | GHRH fragment (29 AA) | Shorter half-life GH research; sleep-cycle GH | Not approved for general use in Canada |
| CJC-1295 (with DAC) | GHRH analog with extended half-life | Sustained GH elevation research | Not approved |
| Ipamorelin | GHRP / ghrelin mimetic | Selective GH release without cortisol/prolactin spike | Not approved |
| MK-677 (Ibutamoren) | Oral ghrelin receptor agonist | Oral-route GH research | Not approved |
For Canadian researchers entering the GH-secretagogue space, tesamorelin sits in a unique spot. It’s the only compound in this category with Health Canada approval, even if for a narrow indication. That regulatory status makes it the reference compound for GHRH analog pharmacology research.
π₯ Watch: Growth Hormone-Releasing Hormone Mechanism Explained
Dr. Andrew Huberman’s lecture covers the major categories of peptides currently in use for therapeutic and research purposes, including GHRH analogs and growth hormone secretagogues like tesamorelin. A solid reference for understanding the GH-related peptide research category.
The Approved Prescription Tesamorelin Market: Egrifta SV
Egrifta SV is made by Theratechnologies Inc., a Montreal-based biopharmaceutical company. The “SV” designation refers to the smaller-volume reformulation that replaced the original Egrifta product. It improved the patient administration experience while keeping the same active ingredient.
| Product Detail | Specification |
|---|---|
| Brand name | Egrifta SV |
| Active ingredient | Tesamorelin acetate |
| Manufacturer | Theratechnologies Inc. (Montreal, Quebec) |
| Health Canada approved indication | Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy |
| Format | Lyophilized powder for reconstitution; daily subcutaneous injection |
| Standard dose | 1.4 mg daily (post-reconstitution) |
| Generic available? | Not in Canada |
How to Buy Approved Prescription Tesamorelin (Egrifta SV) in Canada
- Talk to a licensed Canadian healthcare provider. Usually an HIV specialist, infectious disease physician, or endocrinologist who’s familiar with HIV-associated lipodystrophy.
- Get a prescription for Egrifta SV if it’s clinically appropriate based on the diagnosis.
- Fill the prescription at a licensed Canadian pharmacy. Usually specialty pharmacies, given the narrow indication and storage requirements.
- Insurance coverage. Egrifta SV coverage typically requires special authorization from provincial drug plans and private insurers given the specialized indication. Theratechnologies runs patient support programs to help with coverage.
This article focuses mostly on the research-grade tesamorelin market. For prescription Egrifta SV, your starting point is your healthcare provider, not a research peptide retailer.
Why Researchers Buy Research-Grade Tesamorelin in Canada
The research applications driving Canadian demand for research-grade tesamorelin span several investigative categories well beyond the narrow Egrifta SV approved indication:
| Research Application | What’s Being Studied |
|---|---|
| GHRH receptor pharmacology | Receptor binding kinetics, downstream signaling pathways |
| Pulsatile GH release modeling | How exogenous GHRH analogs preserve or restore physiological GH pulse patterns |
| Visceral adipose tissue research | Mechanism of action behind tesamorelin’s documented visceral fat reduction effects |
| Comparative GH-secretagogue research | Tesamorelin vs. CJC-1295 vs. sermorelin head-to-head studies |
| Combination protocol research | GHRH analog + GHRP combinations (e.g., tesamorelin + ipamorelin in research protocols) |
| Cognitive / neurological research | Emerging research into GH/IGF-1 effects on cognitive function in aging models |
| NAFLD / liver fat research | Tesamorelin’s effects on hepatic fat content in metabolic dysfunction models |
The 7-Point Verification Framework for Research-Grade Tesamorelin
| # | Verification Signal | Why It Matters for Tesamorelin Specifically |
|---|---|---|
| 1 | Independent third-party COA per batch | Self-issued COAs aren’t independent verification. Janoshik or equivalent is the 2026 standard |
| 2 | HPLC purity β₯99% | Tesamorelin’s 44 amino acids put it among the longer research peptides. Purity matters more |
| 3 | Mass spectrometry sequence verification | Confirms all 44 amino acids are correctly assembled. Non-negotiable for GHRH analog research |
| 4 | Endotoxin testing | Bacterial contamination is invisible on purity tests. Metabolic-pathway research is vulnerable |
| 5 | Domestic Canadian shipping | Skips CBSA seizure risk; keeps cold-chain integrity |
| 6 | Tamper-evident packaging | Counterfeit defense layer for any specialized research compound |
| 7 | Public lab results page | Vendors hiding COAs behind email-only requests are running opaquely |
1. Nox Peptides β The Documentation Standard
Site: noxpeptides.ca
Standout claim: Only Canadian retail supplier publishing both purity AND endotoxin lab reports on tesamorelin
Best for: Researchers who want the deepest documentation chain on the GHRH analog reference compound
Nox Peptides earns the #1 spot because tesamorelin research demands documentation depth most Canadian retailers don’t provide. Most suppliers stop at HPLC purity COAs. Nox publishes those reports plus endotoxin testing, a step usually reserved for GMP pharmaceutical manufacturing.
For tesamorelin specifically, that documentation depth matters because the compound is a 44-amino-acid peptide with secondary structure sensitivity. Synthesis quality, batch-to-batch consistency, and contamination control all influence research outcomes. Endotoxin contamination can independently trigger inflammatory responses that confound hormone research outcomes. Invisible on a standard purity COA but critical for any pharmacological investigation.
The Nox brand framing leans engineering-first: NΓX is a performance science system engineered for measurable human output, designing, synthesizing, and validating precision performance compounds with documented traceability and authorized release. The catalog covers the broader GH-secretagogue category. Research-grade tesamorelin alongside CJC-1295, sermorelin, ipamorelin, and MK-677, which makes comparative GH-secretagogue research from a single supplier doable.
What you actually get with Nox tesamorelin:
- Per-batch purity reports verified by an independent third-party lab
- Per-batch endotoxin reports, invisible on standard COAs at every other Canadian retailer
- Mass spectrometry sequence verification, confirming all 44 amino acids
- Domestic Canadian dispatch with Canadian customer service
- Catalog adjacency: full GH-secretagogue category for comparative research
Browse the research-grade tesamorelin listing and per-batch lab reports at noxpeptides.ca.
2. Canadian Peptides β Established Generalist with GH-Class Coverage
Site: canadianpeptides.ca
Catalog focus: Long-running domestic generalist with full GH-secretagogue category coverage
Canadian Peptides has been one of the longer-running domain names in this space and carries broad GH-secretagogue inventory. Tesamorelin alongside sermorelin, CJC-1295, ipamorelin, and MK-677. They market a 99%+ purity standard with lab-tested and COA verified products, plus fast shipping across Canada.
For researchers building comparative GH-secretagogue studies, Canadian Peptides offers a meaningful single-vendor inventory edge. The product framing is research-clear with consistent disclaimer language across the catalog: for research use only, not for human consumption, medical use, or diagnostic applications.
3. Polar Peptides β Education-Heavy Sourcing
Site: polarpeptides.ca
Catalog focus: Detailed product education modules across the GH-secretagogue category
Polar Peptides has built itself out as one of the most education-focused Canadian suppliers, with detailed product framing across the metabolic and GH-secretagogue categories. Their tesamorelin listing publishes full molecular profiles, vial dimensions, fill percentages, and reconstitution guidance.
That depth of pre-purchase information is uncommon in the Canadian online peptide space and cuts the post-purchase support burden meaningfully. For researchers entering the GH-secretagogue category for the first time, Polar’s educational layer helps clarify the meaningful differences between GHRH analogs (tesamorelin, CJC-1295, sermorelin) and GHRP / ghrelin mimetics (ipamorelin, MK-677).
Standard logistics: orders ship within 24 hours MondayβFriday from a Canadian fulfillment centre, with 2β5 business day delivery, and Interac e-Transfer accepted as the standard Canadian payment method.
4. Peptide Warehouse β Catalog Breadth
Site: peptidewarehouse.ca
Catalog focus: Broad metabolic and GH-secretagogue inventory
Peptide Warehouse runs one of the broader Canadian metabolic and GH-related peptide catalogs, with research-grade tesamorelin alongside the full GH-secretagogue family: CJC-1295 (with and without DAC), sermorelin, ipamorelin, GHRP-2, GHRP-6, and MK-677. The site advertises HPLC tested products and a wide range of peptides, bacteriostatic water, and supporting research consumables.
For researchers running comparative studies across the GH-secretagogue class, having all the comparison compounds available from one supplier simplifies sourcing logistics and creates batch-consistency across the experimental panel. That comparative-study utility is uncommon among Canadian suppliers. Most carry tesamorelin as part of a smaller GH-secretagogue offering rather than alongside its full mechanistic peer group.
5. Growth Guys β Janoshik Public Verification
Site: growthguys.is
Catalog focus: Janoshik-verified batch testing across GH-related peptides
Growth Guys has built a strong reputation in the Canadian peptide community specifically around Janoshik Analytical batch testing, with verifiable purity data published per product variant. The vendor name itself reflects the catalog focus: GH-related compounds are the core specialty, with tesamorelin sitting prominently alongside CJC-1295, sermorelin, ipamorelin, and growth-related research peptides.
For tesamorelin specifically, the Janoshik verification matters because anyone can publish a PDF COA. Janoshik’s public verification system at janoshik.com lets researchers look up specific batch results independently using a unique key, confirming the supplier’s published COA matches the actual lab report. For a 44-amino-acid GHRH analog where synthesis quality directly affects research outcomes, that verification step is meaningful.
6. NCRP (National Canadian Research Peptides)
Site: ncrpcanada.com
Catalog focus: Manufacturer-direct sourcing with detailed handling guidance
NCRP runs one of the more transparent manufacturer-direct outfits in the Canadian market. All of their products are made in Canada and certified greater than 98% pure by HPLC, with mass spectroscopy used to confirm sequence accuracy.
Their published handling guidance is unusually detailed: peptides should be stored in a dry, cool, dark place, with refrigeration at 4Β°C or colder away from bright light recommended for best preservation, and reconstituted only with bacteriostatic water using an insulin needle and gentle injection technique. For a 44-amino-acid peptide like tesamorelin where reconstitution technique meaningfully affects peptide integrity, that operational documentation depth matters.
7. Clinical Peptides β Domestic Synthesis + Loyalty Pricing
Site: clinicalpeptides.net (also clinicalpeptides.ca)
Catalog focus: Canadian-synthesized peptides with rewards program economics
Clinical Peptides has leaned into Canadian-domestic synthesis with loyalty mechanics that make sense for repeat tesamorelin buyers. Most of their peptides are now made in Canada, synthesized, purified, and completed within Canada, with in-house synthesis and strict adherence to USP-grade excipient standards ensuring purity, consistency, and full traceability.
The loyalty mechanics: for every $1 spent, customers earn 1 point, with every 100 points converting into a $5 discount toward future orders, plus a referral program offering 15% off for new customers and a $20 credit per successful referral. For ongoing tesamorelin research procurement, the rewards add up meaningfully across an extended program.
8. Amino Pure Canada β Format Flexibility
Site: aminopurecanada.ca
Catalog focus: Multiple administration formats for GH-secretagogue compounds
Amino Pure Canada offers research peptides across format options uncommon among Canadian suppliers: capsules, vials, and atomizer sprays. HPLC analysis and GMP manufacturing conditions back every batch at 99%+ purity with full Certificate of Analysis documentation.
Logistics: free shipping on all orders over $200 CAD, plus same-day shipping on orders placed and paid before 2 PM EST, with Canada-wide coverage to Ontario, Quebec, Alberta, and British Columbia. For researchers comparing administration-route bioavailability differences across GH-secretagogue compounds, the format flexibility is meaningful, though the lyophilized vial format remains the gold standard for tesamorelin specifically.
9. Purity Peptides β North American Sourcing Chain
Site: puritypeptides.ca
Catalog focus: North American-sourced research peptides with per-batch documentation
Purity Peptides stands apart with an explicit North American sourcing narrative, marketed as North American sourced and 3rd-party tested (not China), with verified COAs and purity reports on every product. Their position is that peptide accuracy depends on synthesis quality, raw materials, and controlled production environments. Environmental exposure, temperature, and handling conditions directly affect molecular stability.
For Canadian tesamorelin buyers working under institutional procurement requirements that mandate documented North American supply chains, Purity Peptides fits cleanly into the workflow. Their disclaimer language is research-clear: for laboratory research use only, not for human consumption.
10. VPeptide β Public Batch Verification
Site: vpeptide.com
Catalog focus: Research peptides with public Janoshik batch verification
VPeptide carries a research peptide catalog with the framing ultra-pure, lab-tested, and double-verified peptide quality, supplied for laboratory research applications. The disclaimer language stays appropriately cautious throughout the catalog.
VPeptide publishes per-batch testing references through Janoshik Analytical’s public testing system, which is the third-party verification standard most researchers now look for. For tesamorelin buyers who treat verifiable lab links as a non-negotiable requirement, VPeptide hits the bar.
11. PeptidePro Canada β Ontario-Based Dispatch
Site: peptideprocanada.com
Catalog focus: Focused catalog with central-Canada fulfillment speed
PeptidePro Canada offers a focused catalog with Ontario-based fulfillment. Products are usually supplied as lyophilized material in glass vials, shipped from Ontario, Canada, and provided strictly for non-clinical laboratory research by qualified facilities and trained personnel.
The Ontario-based fulfillment is a meaningful logistics edge for researchers in central Canada. Toronto, Ottawa, and Montreal labs typically see same-province or next-province delivery times within 1β2 business days. Certificates of Analysis are published directly on product pages alongside detailed quality information rather than gated behind email requests.
12. Boss Peptides β Educational Content Hub
Site: bosspeptides.ca
Catalog focus: Peptide catalog paired with extensive buyer-side educational content
Boss Peptides has positioned itself partly as a supplier and partly as an educational resource. Their published verification framework lines up with serious 2026 standards: check for Health Canada approval, avoid injectable peptides sold without a prescription, and demand third-party testing. Legitimate research suppliers publish Certificates of Analysis (COAs) from independent labs, showing purity, identity, and sterility.
For tesamorelin specifically, the dual-market reality (approved Egrifta SV vs research-grade compound) makes buyer-side education especially useful. Boss Peptides’ content depth helps new researchers understand the regulatory framework before sourcing decisions get made.
π Side-by-Side: Canadian Research-Grade Tesamorelin Suppliers in 2026
| # | Supplier | Independent COA | Endotoxin Data | Full GH-Class Catalog | Differentiator |
|---|---|---|---|---|---|
| 1 | Nox Peptides | β Public | β Public | β | Purity + endotoxin transparency |
| 2 | Canadian Peptides | β | On request | β | Long operating history; broad catalog |
| 3 | Polar Peptides | β | On request | β | Education-heavy product framing |
| 4 | Peptide Warehouse | β | On request | β | Full GH-secretagogue family catalog |
| 5 | Growth Guys | β Janoshik | On request | β | GH-specialty + public batch verification |
| 6 | NCRP | β | On request | Partial | Manufacturer-direct |
| 7 | Clinical Peptides | β | On request | β | Loyalty rewards program |
| 8 | Amino Pure Canada | β | On request | Partial | Multiple format options |
| 9 | Purity Peptides | β Per-batch | On request | Partial | North American sourcing |
| 10 | VPeptide | β Janoshik | On request | Partial | Public batch verification |
| 11 | PeptidePro Canada | β Public on page | On request | Partial | Ontario-based dispatch |
| 12 | Boss Peptides | β | On request | Partial | Educational hub depth |
π Research-Grade Tesamorelin Pricing in Canada β 2026 Market Reality
| Vial Strength | Typical 2026 Canadian Range (CAD) | Per-Mg Range | Notes |
|---|---|---|---|
| 5mg | $80β$130 | ~$16β$26/mg | Common research starter format |
| 10mg | $130β$200 | ~$13β$20/mg | Better per-mg economics for ongoing research |
Prescription Egrifta SV Pricing in Canada (For Comparison)
| Prescription Product | Approximate 2026 Canadian Cost | How to Buy |
|---|---|---|
| Egrifta SV | ~CAD $2,000+/month at full retail | Prescription + licensed pharmacy; provincial drug plan special authorization typically required |
| Generic tesamorelin | Not available in Canada, patent protection ongoing | β |
The price gap between the two markets is substantial, and reflects a fundamentally different cost structure. Egrifta SV is a specialized HIV-associated lipodystrophy treatment with limited indication and complex insurance coverage requirements. Research-grade tesamorelin sits in the broader research peptide market at standard pricing structures.
Storage, Handling & Reconstitution: Tesamorelin-Specific Notes
| Stage | Protocol |
|---|---|
| Receipt | Inspect packaging integrity; verify tamper-evident seals; refrigerate immediately |
| Lyophilized storage (short-term) | 2β8Β°C refrigeration, away from light |
| Lyophilized storage (long-term) | β20Β°C freezer, away from light; tesamorelin is among the more storage-sensitive research peptides |
| Reconstitution diluent | Bacteriostatic water, not plain sterile water for multi-use vials |
| Reconstitution technique | Inject diluent slowly down vial wall; gentle swirling, no aggressive shaking |
| Post-reconstitution storage | 2β8Β°C refrigerated; tesamorelin reconstituted solution has a shorter usable window than some other research peptides |
| Disposal | Per municipal hazardous waste guidelines |
At 44 amino acids, tesamorelin is among the longer research peptides commonly available in Canada, and the reconstituted compound has shorter post-reconstitution stability than smaller peptides like BPC-157. Plan reconstitution timing accordingly for research protocol efficiency.
π Authority Sources for Tesamorelin Buyers
Before any purchase decision, every Canadian tesamorelin buyer should review these primary sources:
- π¨π¦ Health Canada β Drug Product Database (verify Egrifta SV approved status and DIN)
- π¨π¦ Health Canada β Think twice before injecting peptides bought online
- ποΈ Theratechnologies Inc. β Canadian biopharmaceutical company that developed tesamorelin
- π PubMed Central β Tesamorelin: A Growth Hormone-Releasing Hormone Analog Pharmacology Review
- π NEJM β Tesamorelin in HIV-Associated Abdominal Adiposity (foundational Phase 3 trial)
- π° CBC News β Health Canada warns against unauthorized peptides (April 2026)
- βοΈ College of Physicians & Surgeons of Alberta β Unauthorized injectable peptides
- π McMaster University β Research-Only Peptides Q&A
- π McGill University Office for Science and Society
- π World Anti-Doping Agency β Prohibited List
Frequently Asked Questions
Can I legally buy tesamorelin in Canada?
Yes, through two separate routes. Approved prescription tesamorelin (Egrifta SV) is bought with a prescription from a licensed Canadian pharmacy for the specific approved indication of HIV-associated lipodystrophy. Research-grade tesamorelin is bought from Canadian domestic peptide suppliers strictly for laboratory research use, without a prescription requirement, but it can’t legally be sold or marketed for human consumption.
What’s the approved indication for Egrifta SV in Canada?
Egrifta SV is approved by Health Canada specifically for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. It’s not approved for general weight management, growth hormone deficiency, anti-aging, athletic performance, or any indication outside the HIV-associated lipodystrophy context.
Is tesamorelin a Canadian-developed drug?
Yes. Tesamorelin was developed by Theratechnologies Inc., a Montreal-based biopharmaceutical company. Egrifta SV is one of the relatively few peptide drugs that came out of Canadian pharmaceutical research and development. The Canadian connection is part of why tesamorelin has particular significance in domestic peptide research conversations.
Can I get prescribed tesamorelin for non-HIV indications in Canada?
Off-label prescribing exists, but Egrifta SV’s approved Canadian indication is narrow (HIV-associated lipodystrophy). Off-label use for other indications would be at physician discretion and typically without provincial drug plan coverage. Most Canadian researchers studying tesamorelin’s broader pharmacology source research-grade material rather than work through off-label prescribing.
What’s the typical price for research-grade tesamorelin in Canada?
Research-grade tesamorelin pricing in 2026 typically runs from roughly CAD $80 to $200 per vial depending on dosage strength (commonly 5mg or 10mg) and supplier. Higher-dose vials offer better per-milligram economics, with 10mg vials typically in the ~$13β$20/mg range versus ~$16β$26/mg for 5mg formats.
How does tesamorelin compare to other GH-secretagogues like CJC-1295 or sermorelin?
All three are GHRH analogs but differ in structure and pharmacokinetics. Tesamorelin is a stabilized 44-amino-acid GHRH analog with an established Health Canada-approved indication. CJC-1295 (with DAC) is a GHRH analog with extended half-life of roughly 6β8 days. Sermorelin is a shorter 29-amino-acid GHRH fragment with a shorter half-life. Each has different research applications based on the target pulse pattern and study duration.
How does tesamorelin compare to GHRPs like ipamorelin?
Tesamorelin is a GHRH analog. It works by binding GHRH receptors at the pituitary. GHRPs (Growth Hormone-Releasing Peptides) like ipamorelin bind to ghrelin receptors and switch on a different signaling pathway. The two pathways can be combined in research protocols (GHRH + GHRP synergy), which is why combination protocols are a meaningful research category.
Why is research-grade tesamorelin so much cheaper than Egrifta SV?
The two products work in entirely different markets with different regulatory and commercial frameworks. Egrifta SV pricing reflects pharmaceutical-grade GMP manufacturing, full clinical safety review, specialized cold-chain distribution, patient support programs, and pharmaceutical-industry commercialization economics. Research-grade tesamorelin sits in the broader research peptide market at standard research-supplier pricing structures.
Can I import tesamorelin from US suppliers?
Importing peptides into Canada from international sources carries CBSA seizure risk that’s been at record-high enforcement levels in 2026. Beyond seizure risk, peptides held in non-climate-controlled customs warehouses degrade quickly, particularly relevant for a 44-amino-acid compound with secondary-structure sensitivity. Domestic Canadian sourcing avoids both problems.
What’s the WADA status of tesamorelin?
Growth hormone-releasing factors and their analogs, including tesamorelin, fall under World Anti-Doping Agency regulations. Athletes subject to WADA Code or any sport-governing-body anti-doping rules should check with their compliance officer for current prohibited substance status before sourcing or possessing any GH-secretagogue compound.
βοΈ Legal Disclaimers
…Two Distinct Markets. This article addresses two separate tesamorelin markets in Canada: (1) approved prescription medication (Egrifta SV, made by Theratechnologies Inc.) which requires a prescription from a licensed Canadian healthcare provider for the specific approved indication of HIV-associated lipodystrophy and dispensing by a licensed Canadian pharmacy, and (2) research-grade tesamorelin sold by Canadian peptide suppliers strictly for laboratory research use only. The two markets aren’t equivalent and shouldn’t be conflated.
Research Use Only. Research-grade tesamorelin products referenced in this article are sold and intended strictly for laboratory research and in vitro experimental use. They are not intended for human consumption, injection, ingestion, inhalation, topical application, or any other form of human use, nor for veterinary use, food, or cosmetic applications.
Approved Drug Pathway for Human Use. Anyone seeking tesamorelin for HIV-associated lipodystrophy treatment should talk to a licensed Canadian healthcare provider and get authorized prescription Egrifta SV through a licensed Canadian pharmacy. Authorized products carry a Health Canada Drug Identification Number (DIN) on the label.
Narrow Approved Indication. Egrifta SV is approved by Health Canada exclusively for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Use for any other indication, including
